Clinical research in oncology. Are patient safety and data acquisition compatible?

被引:0
|
作者
Illhardt, F. J. [1 ]
Unger, C. [2 ]
机构
[1] Klinikum Albert Ludwigs Univ, Eth Kommiss, D-79110 Freiburg, Germany
[2] Klin Tumorbiol, D-79106 Freiburg, Germany
来源
ONKOLOGE | 2009年 / 15卷 / 10期
关键词
Vulnerability; Equipoise; Data (Safety) Monitoring Committee; Publication; Pallitive medicine; TRIALS; ETHICS;
D O I
10.1007/s00761-009-1694-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncological research is concerned with developing new substances, new chemotherapeutical combinations, dietetics, psychology, retrieval of data, immunomodulation and accommodation. All these research areas show a conflict between the safety of patients and the retrieval of data. Models for a solution are 1) the exclusion of a not yet established medicine which benefits the interests of patients and 2) the analysis and balancing which covers both approaches without exclusion. Balance is the preferred model because it allows developments which support the safety of patients. What these conflicts consist of and what leads to a solution from an ethical standpoint is discussed in the following issues: vulnerability, informed consent, the principle of equipoise (ratio of preferring interests), data monitoring committees, publication and research in fields of palliative medicine.
引用
收藏
页码:989 / +
页数:7
相关论文
共 50 条
  • [22] THE PATIENT AS PARTNER - ETHICS IN CLINICAL ONCOLOGY RESEARCH
    VEATCH, RM
    JOHNS HOPKINS MEDICAL JOURNAL, 1982, 151 (04): : 155 - 161
  • [23] TIME IN ONCOLOGY. GLIOBLASTOMA REAL-WORLD DATA
    Macia i Garau, M.
    Calduch, A. Lucas
    Exposito, N. Garcia
    NEURO-ONCOLOGY, 2023, 25
  • [24] Family history of cancer and clinical outcome in pediatric oncology.
    Schiffman, Joshua David
    Smith, Ken R.
    Burningham, Zachary
    Kohlmann, Wendy
    Curtin, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Clinical oncology pharmacist: Effective contribution to patient safety
    Duarte, Natalia C.
    Barbosa, Cristina R.
    Tavares, Mariane G. R.
    Dias, Lara P.
    Souza, Rafael N.
    Moriel, Patricia
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (07) : 1665 - 1674
  • [26] INTERDISCIPLINARY APPROACH TO RESEARCH BIOPSY ACQUISITION IN ONCOLOGY CLINICAL TRIALS
    Schroeder, Katy
    Roessler, Jarrod
    Zindars, Stacey
    Rau, Mary
    Polak, Elizabeth
    Fleischman, Jennifer
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [27] Clinical studies in dermatological oncology. Recommendations for the recruitment of patients
    Nashan, D
    Strittmatter, G
    Schafer, U
    Lehmkuhl, J
    Frosch, PJ
    HAUTARZT, 1997, 48 (02): : 100 - 102
  • [28] Evaluation of the role of confirming responses in clinical trials in oncology.
    Perez-Gracia, JL
    Muñoz, M
    Wu, J
    Carrasco, E
    Garcia-Ribas, I
    Peiro, A
    Blatter, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 536S - 536S
  • [29] Drug safety in paediatric oncology. The contribution of therapeutic trials to pharmacovigilance
    Butterfass-Bahloul, T.
    Boos, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (08) : 716 - +
  • [30] The new mutational model in oncology. What changes in welfare, clinical practice, research, and regulatory procedures?
    Normanno, N.
    Curigliano, G.
    Jommi, C.
    Martini, N.
    Marchetti, A.
    Marchetti, P.
    Pedrini, A.
    Pruneri, G.
    ANNALS OF ONCOLOGY, 2019, 30